NEW YORK, NY / ACCESSWIRE / June 29, 2022 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Amazon.com, Inc. (NASDAQ:AMZN)
CONTACT JAKUBOWITZ ABOUT AMZN:
https://claimyourloss.com/securities/amazon-com-inc-loss-submission-form/?id=29355&from=1
Class Period : February 1, 2019 - April 5, 2022
Lead Plaintiff Deadline : July 5, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Amazon engaged in anticompetitive conduct in its private-label business practices, including giving Amazon products preference over those of its competitors and using third-party sellers' non-public data to compete with them; (ii) the foregoing exposed Amazon to a heightened risk of regulatory scrutiny and/or enforcement actions; (iii) Amazon's revenues derived from its private-label business were in part the product of impermissible conduct and thus unsustainable; and (iv) as a result, the defendants' public statements throughout the class period were materially false and/or misleading.
Apyx Medical Corporation (NASDAQ:APYX)
CONTACT JAKUBOWITZ ABOUT APYX:
https://claimyourloss.com/securities/apyx-medical-corporation-loss-submission-form/?id=29355&from=1
Class Period : May 12, 2021 - March 11, 2022
Lead Plaintiff Deadline : August 5, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) a significant number of Apyx's Advanced Energy products were used for off-label indications; (2) such off-label uses led to an increase in the number of medical device reports filed by Apyx reporting serious adverse events; (3) as a result, the Company was reasonably likely to incur regulatory scrutiny; (4) as a result of the foregoing, the Company's financial results would be adversely impacted; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Unilever PLC (NYSE:UL)
CONTACT JAKUBOWITZ ABOUT UL:
https://claimyourloss.com/securities/unilever-plc-loss-submission-form/?id=29355&from=1
This lawsuit is on behalf of all persons who purchased or otherwise acquired Unilever American Depositary Receipts between September 2, 2020 and July 21, 2021, inclusive.
Lead Plaintiff Deadline : August 15, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: a) in July 2020, the board of Ben & Jerry's, one of Unilever's marquee brands, passed a resolution to end sales of its ice cream in "Occupied Palestinian Territory" ; and b) this boycott decision risked adverse governmental actions for violations of laws, executive orders, or resolutions aimed at discouraging boycotts, divestment, and sanctions of Israel adopted by 35 U.S. states.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law
View source version on accesswire.com:
https://www.accesswire.com/706939/LAWSUITS-FILED-AGAINST-AMZN-APYX-and-UL--JAKUBOWITZ-LAW-PURSUES-SHAREHOLDERS-CLAIMS